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Notch genes encode a highly conserved fam-
ily of transmembrane receptors that are involved 
in various developmental programs and cell fate 
decisions (Artavanis-Tsakonas et al., 1999). The 
broad range of processes that require Notch 
signaling is reflected by the variety of human 
diseases that result from mutations in compo-
nents of the Notch signaling pathway (Koch 
and Radtke, 2010; Lobry et al., 2011). The 
mammalian genome encodes for 4 Notch re-
ceptors (Notch1–4) that can be activated by 
binding of ligands that belong to the Serrate-
like (Jagged1 and Jagged2) or Delta-like (DLL1, 
DLL3, and DLL4) families (Kopan and Ilagan, 
2009). Although the biological relevance of all 
these possible ligand–receptor interactions is still 
being elucidated, it is clear that they have a crit-
ical role in regulating normal developmental pro-
cesses (Benedito et al., 2009). Ligand–receptor 
interactions lead to two sequential proteolytic 
cleavages of the Notch receptor and these are 
mediated by a metallo-protease and a multi-
protein complex with -secretase activity, respec-
tively. After cleavage, the active form of Notch 
(intracellular Notch [ICN]) migrates to the nu-
cleus to activate transcription of downstream 
target genes, such as Hes1, Nrarp, and Deltex1.
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In humans, high Notch activation promotes  T cell development, whereas lower levels pro-
mote -lineage differentiation. How these different Notch signals are generated has remained 
unclear. We show that differential Notch receptor–ligand interactions mediate this process. 
Whereas Delta-like 4 supports both TCR- and - development, Jagged1 induces mainly 
-lineage differentiation. In contrast, Jagged2-mediated Notch activation primarily results in 
 T cell development and represses -lineage differentiation by inhibiting TCR- formation. 
Consistently, TCR- T cell development is rescued through transduction of a TCR- transgene. 
Jagged2 induces the strongest Notch signal through interactions with both Notch1 and Notch3, 
whereas Delta-like 4 primarily binds Notch1. In agreement, Notch3 is a stronger Notch activa-
tor and only supports  T cell development, whereas Notch1 is a weaker activator supporting 
both TCR- and - development. Fetal thymus organ cultures in JAG2-deficient thymic 
lobes or with Notch3-blocking antibodies confirm the importance of Jagged2/Notch3 signaling 
in human TCR- differentiation. Our findings reveal that differential Notch receptor–ligand 
interactions mediate human TCR- and - T cell differentiation and provide a mechanistic 
insight into the high Notch dependency of human  T cell development.
© 2013 Van de Walle et al. This article is distributed under the terms of an 
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six months after the publication date (see http://www.rupress.org/terms). After 
six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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colonization by bone marrow–derived hematopoietic progeni-
tor cells (HPCs). In humans, uncommitted CD34+CD1a thy-
mocytes gradually commit to the T cell fate under the influence 
Notch signaling is of critical importance during T cell de-
velopment (Radtke et al., 2010; Yashiro-Ohtani et al., 2010). 
In adult life, T lymphocytes are generated in the thymus after 
Figure 1. Notch ligands differentially impact TCR- versus TCR- T cell development. (A) Kinetic flow cytometric analysis of CD34+CD4CD1a 
uncommitted intrathymic progenitors cultured for 11 or 18 d on OP9 cells expressing the different Notch ligands (DLL4, JAG1, or JAG2) as indicated above the 
dot plots. Numbers in the quadrants indicate the percentage of the corresponding populations. Dot plots shown are representative of three independent  
experiments. (B–E) Corresponding cell numbers of the kinetic flow cytometric analysis of cultures depicted in A. Graphs show the absolute number of all cells 
(B), CD4+CD8+ DP cells (C), CD3+TCR-+ (D), and CD3+TCR-+ cells (E). Data shows the mean of three independent experiments and error bars show SEM. 
(F and G) Relative (F) or absolute (G) frequency of -only, -only, or bipotent - and -containing wells (left graphs) or frequency of TCR- or TCR-  
T cell–containing wells (right graphs) within single-plated CD34+CD4–CD1a+ T-lineage committed thymocytes on the different OP9 cell lines, as indicated in 
the graph, that showed T cell reconstitution after 20 d of coculture. Data shows the mean of three independent experiments and error bars show SEM.
 o
n
 M
ay 23, 2013
jem.rupress.org
D
ow
nloaded from
 
Published March 25, 2013
JEM Vol. 210, No. 4 
Article
685
of the thymic microenvironment. This results in the induction 
of CD1a expression and the initiation of T cell receptor gene 
rearrangements at the TCR-, -, and - loci (Dik et al., 2005). 
While in frame, TCR- and - rearrangements will induce the 
generation of CD3+  T cells, and a functional TCR- chain 
will pair with the surrogate pre–TCR- chain to form the pre-
TCR complex that drives massive proliferation and differentia-
tion toward CD4+CD8+ double-positive (DP) cells, a process 
called -selection (Taghon et al., 2009). At the DP stage, TCR- 
rearrangements are initiated to replace the pre-TCR com-
plex with a fully functional TCR- chain, and this allows the 
cells to undergo positive and negative selection, thereby gener-
ating immune-competent, non–self-reactive CD4+ and CD8+ 
single-positive -lineage T cells (Blom and Spits, 2006; Plum 
et al., 2008).
In the mouse, induction of T cell development in HPCs is 
critically dependent on the Notch1–DLL4 interaction in the 
thymus (Radtke et al., 1999; Wilson et al., 2001; Hozumi et al., 
2008; Koch et al., 2008). In the absence of either one of these 
proteins, thymus colonizing HPCs mainly adopt a B cell fate 
instead of differentiation along the T cell lineage. As a result 
of this early alteration in lineage choice, it is still unclear if dif-
ferential Notch receptor–ligand interactions are involved in 
intrathymic cell fate decisions within the T-lineage pathway. 
This is of critical importance because it is well established that 
differences in Notch signal strength can influence TCR- 
and - T cell development (De Smedt et al., 2002; García-
Peydró et al., 2003; Van de Walle et al., 2009), but it is unclear 
how this is regulated in vivo. Given our recent finding that dif-
ferent Notch ligands induce differences in Notch signal strength 
when activating the Notch1 receptor, and our observation 
that different Notch ligands and receptors are expressed in the 
human postnatal thymus (Van de Walle et al., 2009, 2011), we 
examined which ligand–receptor interactions are involved in 
mediating human TCR- and - T cell development. Our 
findings illustrate that Notch ligands differentially affect both 
developmental processes through preferential interactions with 
specific Notch receptors and show that the Jagged2–Notch3 
axis drives human  T cell development, at the expense of 
-lineage differentiation.
RESULTS
Notch ligands differentially affect TCR-  
and TCR- T cell development
In both mouse and human, Notch signal strength can modulate 
the / T cell lineage choice (Washburn et al., 1997; Ciofani 
et al., 2006; Garbe et al., 2006; Taghon et al., 2006; Van de 
Walle et al., 2009), but the mechanisms through which this is 
achieved are still unknown. Because we have recently shown 
that the Notch ligands DLL4, JAG1, and JAG2 are expressed 
by human thymic epithelial cells (TECs) and that these ligands 
induce different levels of Notch1 signal strength (Van de Walle 
et al., 2011), we investigated their impact on human TCR- 
and TCR- T cell development. Human CD34+CD1aCD4 
uncommitted postnatal thymocytes were driven into the 
CD7+CD1a+ T-lineage pathway upon culture onto OP9-DLL4, 
-JAG1, or -JAG2 and differentiated further into CD4+CD8+ 
DP thymocytes (Fig. 1 A). In contrast, murine uncommitted 
c-Kit+ fetal thymocytes were blocked in T-lineage differen-
tiation when cultured on OP9-JAG1 and failed to generate 
CD44CD25+ double-negative 3 (DN3) or DP thymocytes in 
this condition compared with when cocultured on OP9-DLL4 
or OP9-JAG2 (Fig. 2), illustrating the critical differences in 
Notch signaling requirements during mouse and human T cell 
development (Taghon and Rothenberg, 2008; Archbold, 2009; 
Taghon et al., 2012). Human thymocytes revealed differences 
in T cell outcome, depending on to which Notch ligand the 
intrathymic progenitor cells were exposed. Phenotypic analysis 
revealed preferential differentiation into TCR- T cells on 
OP9-JAG1, whereas DLL4 cultured cells developed into both 
- and -lineage cells (Fig. 1 A). In contrast, OP9-JAG2 
cocultured cells differentiated mainly into TCR- T cells 
(Fig. 1 A). The preferential -lineage differentiation on 
OP9-JAG1 was seen early at day 6 by an increased number of 
CD4+CD8+ DP thymocytes (Fig. 1 C) but finally did not 
result in higher  T cell numbers in these cultures (Fig. 1 E) 
as a result of lower total cell yields compared with OP9-DLL4 
and OP9-JAG2 cocultures (Fig. 1 B). Although there was a 
slight increase in  T cell numbers on day 25 in OP9-JAG2 
compared with OP9-DLL4 cocultures (Fig. 1 D), the most 
prominent difference between both was the strong reduction 
in TCR-–lineage cells on OP9-JAG2 compared with -DLL4, 
as illustrated by the number of DP thymocytes (Fig. 1 C) and 
CD3+TCR-+ T cells (Fig. 1 E). To explore the differential 
lineage outcome more robustly, clonal coculture experiments 
were initiated with CD34+CD1a+CD4 committed T cell pre-
cursors (in contrast to the CD34+CD1aCD4 uncommitted 
Figure 2. Jagged1 fails to support DP differentiation from mouse 
thymocytes. Flow cytometric data of murine c-kit+ fetal thymocytes after 
7 or 10 d of coculture on OP9 stromal cells that express different Notch 
ligands (as indicated above dot plots). Early DN stages are distinguished 
by expression of CD44 and CD25 (top row) and T cell maturation is moni-
tored by the coexpression of CD4 and CD8 (middle row). Development of 
TCR-+CD3+ cells is shown in the bottom row. Results shown are repre-
sentative of three independent experiments.
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the repopulated wells. These data confirmed that DLL4 sup-
ports both TCR- and TCR- T cell differentiation, whereas 
Jagged1 almost exclusively supports  T cell development and 
Jagged2 mainly  T cell differentiation. When looking at the 
clonal outgrowth of all plated wells (Fig. 1 G), no difference 
in TCR- output was observed in OP9-JAG2 cocultured 
cells compared with in OP9-DLL4 cocultures, but instead a 
significant reduction in TCR- output was observed upon 
used above), thereby avoiding any potential effects of differ-
ences in Notch ligands with respect to inducing T-lineage 
commitment. In addition, this is the human thymocyte popu-
lation from which TCR- and TCR- T cells develop-
mentally start to diverge (Van de Walle et al., 2009). Fig. 1 F 
shows the frequency of -only, -only, or bipotent - and 
-containing wells (left graph) or frequency of TCR-– 
or TCR-–containing wells (right graph), but only within 
Figure 3. GSI rescues Jagged2-mediated  
inhibition of -lineage differentiation.  
(A–C) Flow cytometric analysis of CD34+CD4CD1a+ 
progenitors cultured during 19 d on OP9 cells  
expressing the different Notch ligands (DLL4, JAG1, 
or JAG2), as indicated above the dot plots, in the 
presence of different concentrations of GSI, as indi-
cated on the right of the dot plots. Effects of GSI are 
shown on TCR-+CD3+ T cells (A), CD4+CD8+  
DP thymocytes (B), and TCR-+CD3+ T cells (C). Num-
bers in the quadrants indicate the percentage of the 
corresponding populations and data are representa-
tive of three independent experiments. (D–F) Abso-
lute number of TCR-+CD3+ T cells (D), CD4+CD8+ 
DP thymocytes (E), and TCR-+CD3+ T cells (F) of 
cultures shown in A–C. Triangles below graphs indi-
cate an increasing dosage of GSI, corresponding to  
0 µM, 0.2 µM, 0.5 µM, and 1 µM GSI. Data shows the 
mean from three independent experiments (errors 
bars indicate SEM, * = P < 0.05). (G) Quantitative  
RT-PCR analysis of human CD34+ thymic precursors 
after 24 h of culture on equal amounts of DLL4-Fc–, 
JAG1-Fc–, or JAG2-Fc–coated plates. Units of ex-
pression are given relative to GAPDH. Data shows 
the mean of two sets of independent samples (errors 
bars indicate SEM, * = P < 0.05).
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different Notch receptors were expressed by both precursor 
subsets because different Notch ligand–receptor interactions 
could potentially explain this difference. Although Notch2 
seemed an unlikely candidate based on its low but stable ex-
pression in human HSCs and throughout human T cell de-
velopment (Van de Walle et al., 2009), both quantitative real- 
time PCR (Fig. 4 A) and protein expression through FACS 
analysis (Fig. 4 B) showed that, in addition to Notch2, cord 
blood (CB) CD34+ HSCs also express Notch1 but not Notch3, 
whereas thymocytes, already before T cell commitment at the 
CD34+CD1 stage, express both Notch1 and Notch3, sug-
gesting that differential Notch3 expression may account for 
the differences in Notch ligand responses between human 
HSCs and intrathymic progenitors. Indeed, binding studies 
(Fig. 4 C) revealed that Jagged2 can bind to Notch1 and also 
very efficiently to Notch3, whereas in contrast, DLL4 interacts 
with Notch1 but virtually not with Notch3. Jagged1 weakly 
binds to both Notch1 and Notch3. In addition, specific Notch 
receptor reporter assays (Fig. 4 D) confirmed that DLL4 is the 
most powerful ligand to activate Notch1-mediated signaling 
but also revealed that Jagged2 induced the strongest activa-
tion when signaling was mediated through Notch3.
Together, these findings reveal that Jagged2 is a very po-
tent Notch ligand for human thymocytes as a result of its in-
teraction with both Notch1 and Notch3. In contrast, DLL4 
only weakly binds and activates Notch3. Because a strong 
Notch signal favors  T cell development, this suggests an 
important role for Jagged2/Notch3 signaling during TCR- 
T cell development.
Notch3 activation promotes -lineage differentiation  
and inhibits TCR- T cell development
To functionally assess the influence of differential Notch re-
ceptor activation, we transduced uncommitted CD34+CD1a 
human intrathymic progenitors with the constitutive active 
forms of Notch1 and Notch3 (ICN1 and ICN3, respectively) 
and analyzed their impact on human - and -lineage dif-
ferentiation. Consistent with previous findings (De Smedt et al., 
2002), ICN1 enhanced  T cell development and reduced dif-
ferentiation into TCR-+ and CD4+CD8+ cells in a fetal 
thymus organ culture (FTOC) model system, both in terms of 
frequency and absolute cell number (Fig. 5, A and B). Impor-
tantly, ICN3 skewed differentiation toward the -lineage 
choice in a similar manner but much more profoundly com-
pared with ICN1. In addition, we performed coculture ex-
periments on OP9 stromal cells that do not overexpress a 
human Notch ligand, to prevent activation of the endogenous 
Notch receptors that are present on human thymocytes. This 
prevents background differentiation of CD3+TCR-+ or 
CD3+TCR-+ thymocytes as illustrated with control trans-
duced cells (Fig. 5, C and D). Under these conditions, ICN1 
transduced precursors differentiate into both TCR-+ and 
TCR-+ T cells, whereas ICN3 transduced precursors only 
display  T cell potential (Fig. 5, C and D). Consistently, gene 
expression analysis revealed that ICN3 induces a stronger Notch 
signal compared with ICN1, as revealed by their influence on 
OP9-JAG2 coculture (Fig. 1 G), confirming the results from 
the bulk cocultures (Fig. 1 E).
Overall, these results show that Notch ligands critically 
influence human TCR- and TCR- T cell development. 
Although DLL4 supports both - and -lineage differen-
tiation, Jagged1 predominantly supports TCR- but not 
TCR- development. In contrast, Jagged2 mainly supports 
 T cell differentiation at the expense of  T cells.
Jagged2 induces the strongest Notch signal  
in human thymocytes
Because our earlier studies had revealed that high Notch sig-
nal strength supports human TCR- T cell development at 
the expense of TCR- T cell development (De Smedt et al., 
2002;  Van de Walle et al., 2009), the data in Fig. 1 suggest that 
Jagged2 induces the strongest Notch signal in human postnatal 
thymocytes. To investigate this further, we reduced the Notch 
activation signal with different concentrations of -secretase 
inhibitor (GSI) in committed human CD34+CD1a+CD4 
thymocytes, as we have also shown that a decrease in Notch 
signaling activation enhances TCR- T cell development 
(Taghon et al., 2009; Van de Walle et al., 2009). Consistent 
with the idea that Jagged2 induces the strongest Notch signal, 
TCR- (Fig. 3 A) and CD4+CD8+ (Fig. 3 B) differentiation 
could be restored in OP9-JAG2 cocultures at the expense of 
TCR- T cell development (Fig. 3 C). Addition of low GSI 
concentrations also increased the frequencies of TCR-+ 
and CD4+CD8+ cells in Jagged1 and DLL4 cultured cells, 
but to a lesser extent. In agreement, although the number of 
TCR- (Fig. 3 D) and CD4+CD8+ (Fig. 3 E) thymocytes 
consistently and significantly increased upon addition of higher 
concentration of GSI (up to 1 µM) in OP9-JAG2 cocultures, 
such an increase in -lineage cells was only observed with 
lower GSI concentration in OP9-DLL4 cocultures. In addi-
tion, the number of TCR- T cells did not significantly 
decrease with the addition of 1 µM GSI in OP9-JAG2 cocul-
tures, in contrast to OP9-DLL4 and OP9-JAG1 cocultures in 
which higher and significant reductions in  T cells were ob-
served (Fig. 3 F). Also, gene expression analysis showed that 
Jagged2 is a stronger inducer of Notch signaling in human 
CD34+ thymocytes after 24-h exposure to equal amounts 
of coated Fc-tagged Notch ligands. The Notch target genes 
HES1, DTX1, NRARP, and NOTCH3 were all up-regulated 
to a higher level in CD34+ thymocytes exposed to Jagged2 in 
comparison with DLL4 and much stronger compared with 
Jagged1 (Fig. 3 G). Thus, these results reveal that for human 
postnatal thymocytes, Jagged2 is the most potent ligand to in-
duce Notch activation, thereby promoting TCR- T cell de-
velopment and blocking -lineage differentiation.
Notch ligands display preferential receptor binding
The idea that Jagged2 induces the strongest Notch signal in 
human postnatal thymocytes seemed to be in conflict with 
our recent findings with human HPCs in which Delta-like 
4 induces the strongest signal through activation of Notch1 
(Van de Walle et al., 2011). Therefore, we investigated whether 
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Notch3 activation is critical for promoting  
 T cell development
To further show the functional importance of Notch3 activation 
in mediating human TCR- and - T cell development in the 
OP9 coculture system, we inhibited Notch3 activation using spe-
cific blocking antibodies (Li et al., 2008). Inhibition of Notch3 
activation did not significantly alter T cell development in OP9-
DLL4 and OP9-JAG1 cocultures but did significantly decrease 
the frequency of TCR-+ T cells in OP9-JAG2 cocultures 
while increasing the frequency of TCR-+ cells within the 
CD3+ fraction of thymocytes (Fig. 6 A). Although the number of 
both positively (HES1, DTX1, and NRARP) and negatively 
(TCR-C) regulated genes (Fig. 5 E). This stronger induction 
of HES1 and DTX1 expression by ICN3 was confirmed in 
independent experiments with myc-tagged ICN-fusion proteins 
in which even lower amounts of ICN3 protein, compared with 
ICN1 as revealed through FACS-mediated myc staining, still 
induced much stronger expression of these Notch target genes 
(unpublished data). Thus, these findings illustrate that Notch3 
activation results in a stronger downstream Notch signal com-
pared with Notch1 activation and that Notch3 is a strong in-
hibitor of  T cell development.
Figure 4. Notch3 is expressed in uncommitted human thymocytes and is efficiently bound and activated by Jagged2. (A) Quantitative RT-PCR 
analysis of Notch1 and Notch3 expression in freshly isolated human CB CD34+ cells and in different human thymocyte subsets. Units of expression are 
given relative to -actin. Data shows the mean of two to eight sets of independent samples, and error bars indicate SEM. (B) Flow cytometric analysis of 
Notch1 and Notch3 receptor expression on freshly isolated CB or thymocytes. Density plots shown are representative of three independent experiments. 
Isotype staining was performed on total human thymocytes suspension. (C) Staining of control-Fc, Notch1-Fc, and Notch3-Fc fusion proteins to K562 cells 
expressing the different Notch ligands as indicated. Histograms shown are representative of three independent experiments. (D) Luciferase reporter assay of 
U2OS Tet-on flp-in-Notch1 and U2OS Tet-on flp-in-Notch3 cells cotransfected with CBF-luciferase reporter plasmid pGL2-Gal4-luciferase and the normal-
izing plasmid pRL-TK expressing Renilla luciferase. After plasmid transfection, cells were cocultured with K562 expressing DLL4, JAG1, JAG2, or control for 
24 h, and thereafter luciferase activity was measured. Bar graphs show the mean of three independent experiments (error bars indicate SEM, * = P < 0.05).
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thymocytes (Fig. 3 G and not depicted). Because Jagged1 is 
capable of binding to (Fig. 4 C) and activating (Fig. 4 D) 
Notch3, this provided us with a model to test the functional 
importance of Notch3 activation for -lineage differentia-
tion because OP9-JAG1 cocultured human T cell progeni-
tors predominantly differentiate into the TCR-+ T cells. 
 T cells only slightly decreased upon Notch3 inhibition in 
OP9-JAG2 cocultures (Fig. 6 B, P = 0.075), there was a signifi-
cant increase in the number of TCR-+ T cells in these cocul-
tures when a Notch3 blocking antibody was added (Fig. 6 C).
Gene expression analysis had revealed that Jagged1 is not 
efficient at maintaining Notch3 expression in human CD34+ 
Figure 5. Constitutive active Notch3 promotes  T cell development more profoundly and induces a stronger Notch signal compared with 
Notch1. Control, ICN1, or ICN3 transduced CD34+CD4CD1a thymocytes were submitted to FTOC (A and B) or cultured on OP9 stromal cells that were 
not transduced with any Notch ligand (C and D). Numbers in dot plots indicate the percentage of cells for the corresponding populations after 4 wk of 
FTOC (A) or 3 wk of OP9 coculture (C). Dot plots shown are representative for three to four independent experiments. Graphs show the mean absolute 
numbers of TCR-+, TCR-+, or CD4+CD8+ DP thymocytes generated after 3 wk of FTOC (B) or 3 wk of OP9 coculture (D). Data are derived from four 
independent experiments (error bars indicate SEM). (E) Quantitative gene expression analysis of Notch and T cell–related genes in human thymus CD34+ 
cells, sorted for eGFP expression 2 d after transduction with ICN1, ICN3, or control virus. The expression levels are normalized to -actin levels. Data 
shown are the mean of two to three sets of independent samples and error bars show SEM.
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T cells, whereas elevated Notch3 levels further increased  
T cell differentiation (Fig. 6, D and E).
To further investigate the requirement for Jagged2 and 
Notch3 in human  T cell development in a more physio-
logical setting, we performed hybrid human/mouse FTOC 
experiments in which human CD34+ thymocytes were used 
to reconstitute deoxyguanosine-treated fetal day 15 thymic 
lobes from gene-targeted JAG2lox/lox mice that were crossed 
with knockin mice that express the Cre recombinase under the 
control of the Foxn1 gene to induce specific JAG2 deletion in 
the TECs (Fig. 7 A). This resulted in a significant reduction in 
Therefore, we retrovirally transduced a full-length transmem-
brane Notch1 or Notch3 receptor into human CD34+CD1 
T-lineage precursors and cocultured these cells on the various 
OP9 stromal cells. In agreement with our previous data, in-
creased Notch1 or Notch3 activation by DLL4 slightly in-
creased the generation of  T cells (Fig. 6, D and E). More 
importantly, Notch3 expression was capable of significantly 
restoring  T cell development in human T cell progenitors 
in OP9-JAG1 cocultures (Fig. 6, D and E). In the case of 
OP9-JAG2 cocultures, increased Notch1 expression reduced 
the frequency (Fig. 6 D) but not the number (Fig. 6 E) of  
Figure 6. Notch3 signaling is an important driver of human  T cell differentiation. (A) Flow cytometric analysis of CD34+CD4CD1a thymocytes 
after 4 wk of coculture on OP9 stromal cells that express the various Notch ligands and in the presence of control or blocking anti-Notch3 antibody, showing 
TCR- and TCR- staining of CD3+ gated thymocytes. Numbers in dot plots indicate the percentage of cells for the corresponding populations. (B) Absolute 
number of TCR- T cells generated in cultures shown in A. (C) Absolute number of TCR- T cells generated in cultures shown in A. Data are the mean from five 
independent experiments (errors bars indicate SEM, * = P < 0.05). (D) Flow cytometric analysis of CD34+CD4CD1a thymocytes, transduced with control or full-
length Notch1 (FLN1) or full-length Notch3 (FLN3), and cocultured for 3 wk on OP9 cells expressing the different Notch ligands (DLL4, Jagged1, or Jagged2) as 
indicated. Numbers in dot plots show the frequency of TCR- T cells. Data are representative of three independent experiments. (E) Absolute number of TCR-  
T cells generated from cultures shown in D. Data are derived from three independent experiments (errors bars indicate SEM, * = P < 0.05).
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of V1, V2, V3, and V9 expression revealed no differences 
in the usage of these TCR V gene segments between  T cells 
generated in the presence or absence of Jagged2 (Fig. 7 E). 
Furthermore, the addition of blocking Notch3 antibodies to 
FTOC cultures, using deoxyguanosine-treated fetal lobes from 
the number (Fig. 7 B) and frequency (Fig. 7, C and D) of 
human  T cells that developed in JAG2-deficient lobes com-
pared with the control. Such a reduction in human  T cell 
development was not observed when JAG1-deficient fetal 
lobes were used (unpublished data). Flow cytometric analysis 
Figure 7. Jagged2/Notch3 signaling is 
critical for human -lineage  
differentiation. (A) Flow cytometric 
analysis of Jagged2 expression in TECs from 
Jag2lox/loxFoxn1-Cre/ (black histogram), 
Jag2lox/wtFoxn1-Cre+/ (white histogram), 
and Jag2lox/loxFoxn1-Cre+/ (gray histogram) 
fetal thymic lobes. Data are representative of 
three independent experiments. (B) Absolute 
number of human  T cells in FTOCs with 
Jag2lox/loxFoxn1-Cre/ (black bar) and Jag2lox/lox 
Foxn1-Cre+/ (gray bar) fetal thymic lobes. 
Data shows the mean of seven independent 
experiments and error bars indicate the SEM 
(* = P < 0.05). (C) Mean frequency of human  
T cells in FTOCs with Jag2lox/loxFoxn1-Cre/ 
(black bar) and Jag2lox/loxFoxn1-Cre+/ (gray 
bar) fetal thymic lobes. Data show the mean 
of seven independent experiments and error 
bars indicate the SEM (* = P < 0.05). (D) Flow 
cytometric analysis of human T cell develop-
ment in FTOCs with Jag2lox/loxFoxn1-Cre/ 
and Jag2lox/loxFoxn1-Cre+/ fetal thymic lobes. 
Dot plots show CD3 versus TCR- expres-
sion and histograms shown TCR- expres-
sion in CD3+TCR-+ (white histogram) 
versus CD3+TCR- (black histogram) cells, 
gated from human CD45+ cells. Frequen-
cies in dot plots show the frequency of 
-lineage (CD3+TCR-TCR-+) T cells. 
(E) Histograms show V1, V2, V3, and V9 
staining from TCR- gated cells shown in D. 
Numbers indicate the frequency of positive 
cells for the corresponding antigen. Data 
are representative of three independent 
experiments. (F) Absolute number of human 
 T cells in FTOCs with control (black bar) 
and blocking Notch3 antibodies (gray bar). 
Data shows the mean of three independent 
experiments and error bars indicate the SEM. 
(G) Mean frequency of human  T cells in 
FTOCs with control (black bar) and blocking 
Notch3 antibodies (gray bar). (H) Flow cyto-
metric analysis of human T cell development 
in FTOCs with control or blocking Notch3 
antibodies. Dot plots show CD3 versus 
TCR- expression and histograms shown 
TCR- expression in CD3+TCR-+ (white 
histogram) versus CD3+TCR- (black his-
togram) cells, gated from human CD45+ cells. 
Frequencies in dot plots show the frequency 
of -lineage (CD3+TCR-TCR-+) T cells. 
Data are representative for three indepen-
dent experiments.
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wild-type mice, also resulted in a decrease in human  dif-
ferentiation (Fig. 7, F–H). Overall, these findings clearly 
illustrate that Jagged2-mediated Notch3 activation is critical 
for human  T cell development.
TCR transgenes overcome ligand-induced TCR choices
The observed differences in TCR- and TCR- T cell de-
velopment by the different Notch ligand–receptor interactions 
could be the result of preferential outgrowth of cells with a 
particular TCR in those culture conditions rather than a de-
velopmental choice on its own. To gain additional insights, we 
analyzed intracellular TCR- (icTCR-) chain expression in 
developing human T-lineage progenitors exposed to the dif-
ferent Notch ligands, as this is a key early event that distin-
guishes most of the developing -lineage progenitors from 
those differentiating along the  T cell pathway. Although 
virtually all cocultured cells belonged to the T cell lineage as 
shown by intracellular expression of CD3 (Fig. 8 A), Jagged1-
exposed thymocytes contained the highest frequency of 
icTCR-+ cells—slightly higher compared with DLL4 but sig-
nificantly higher compared with thymocytes cocultured on 
OP9-JAG2, which displayed a low frequency of icTCR-+ 
cells (Fig. 8, A and B). To explore the functional importance 
of this reduced TCR- chain expression upon OP9-JAG2 
coculture, human CD34+CD4CD1a postnatal thymocytes 
were transduced with a retrovirus encoding a functional 
TCR- or TCR- chain before coculture of the cells on the 
different OP9 stromal cells. Strikingly, Notch ligands had vir-
tually no differential impact on the outgrowth of thymocytes 
with a functional, rearranged TCR. Progenitors transduced 
with a TCR- chain developed into TCR-+ CD3+ T cells 
and CD4+CD8+ thymocytes on all three Notch ligands 
(Fig. 8, C and D), even on Jagged2, and with similar efficien-
cies compared with DLL4 with respect to the absolute num-
ber of -lineage cells generated (Fig. 8, F and G). In contrast, 
OP9 cocultures initiated with TCR- transduced thymo-
cytes yielded TCR-+ CD3+ T cells on all three Notch 
ligands (Fig. 8, E and H) and reduced TCR- T cell dif-
ferentiation (Fig. 8 F). Even when cocultured on Jagged1, 
precursors can develop into TCR-+ T cells when a functional 
TCR- is provided (Fig. 8 E), although with reduced effi-
ciency (Fig. 8 H).
Thus, the introduction of a functional TCR transgene 
into thymic precursors overcomes the ligand-induced lineage 
outgrowth that is observed with unmanipulated thymocytes. 
These results therefore indicate that Notch ligand–receptor 
interactions do not affect the outgrowth of T cell progenitors 
that express a specific TCR, but that instead they influence 
the developmental pathway of early T cell precursors into either 
TCR-– or TCR-–expressing T cells.
DISCUSSION
During intrathymic T cell development, differentiating T cell 
progenitors migrate to different regions within the thymus 
that provide stage-specific environmental queues that drive 
their further differentiation (Petrie and Zúñiga-Pflücker, 2007). 
One of the most important signaling cascades during early 
T cell development comprises the Notch signaling pathway 
and it is well established that the  versus  T cell lineage 
choice is modulated by differential Notch signal strength in 
both mouse and human (Taghon and Rothenberg, 2008; 
Ciofani and Zúñiga-Pflücker, 2010; Kreslavsky et al., 2010; 
Taghon et al., 2012). However, it has remained unclear which 
receptor–ligand interactions are involved in these processes 
and, moreover, the Notch dependency for TCR- and 
TCR- T cell development was shown to be different be-
tween both species (Washburn et al., 1997; De Smedt et al., 
2002; García-Peydró et al., 2003; Ciofani et al., 2006; Garbe 
et al., 2006; Taghon et al., 2006; Van de Walle et al., 2009). 
Here, we demonstrate that differential Notch receptor–ligand 
interactions control human TCR- and TCR- T cell de-
velopment by inducing different Notch signal strengths and 
show that the Jagged2–Notch3 interaction is critical for human 
 T cell development. Importantly, our data provide a mech-
anistic insight into the high Notch dependency for develop-
ing human  T cells.
In the mouse, it is well established that Notch1-DLL4 
signaling is essential for inducing T cell differentiation in the 
immigrating T cell precursors (Wilson et al., 2001; Hozumi 
et al., 2008; Koch et al., 2008) and we believe that this inter-
action is also involved in inducing early T cell development 
in human. From our previous work, it is clear that Notch1 
activation is responsible for inducing human T cell devel-
opment (Van de Walle et al., 2009, 2011), and although it remains 
to be clarified whether Delta-like 4 or Jagged2 is responsible 
for activating this receptor, the notion that a strong Notch 
signal is critical at this early stage of human T cell develop-
ment (Van de Walle et al., 2009) makes Delta-like 4 the most 
likely ligand (Van de Walle et al., 2011). More importantly, 
Notch1 activation at this early stage of T cell development 
induces high Notch3 expression, as also illustrated previously 
(Van de Walle et al., 2009, 2011), making this newly expressed 
receptor accessible for ligand-mediated Notch activation within 
the thymus.
In both mouse and human, Notch signal strength modu-
lates TCR- and TCR- T cell development (Washburn 
et al., 1997; De Smedt et al., 2002; García-Peydró et al., 2003; 
Ciofani et al., 2006; Garbe et al., 2006; Taghon et al., 2006; 
Van de Walle et al., 2009), a process which, in vivo, occurs in 
the cortex (Petrie and Zúñiga-Pflücker, 2007). We have re-
cently shown that JAG2 is expressed by the majority of human 
cortical TECs, in addition to DLL4 which is less abundantly 
expressed in this region (Van de Walle et al., 2011), indicat-
ing that both ligands can mediate the development of both 
T cell subsets. Consistent with the notion that human   
T cells preferentially develop in the presence of high Notch 
activation (De Smedt et al., 2002; García-Peydró et al., 2003; 
Van de Walle et al., 2009), we show here that Jagged2 pref-
erentially induces human  T cell differentiation by inducing 
the strongest Notch signal in immature thymocytes through 
interactions with both Notch1 and Notch3, in contrast to 
Delta-like 4 which predominantly interacts with Notch1 and 
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inducer of Notch activation compared with Notch1 as illus-
trated by the stronger induction or repression of Notch target 
genes. This additional efficient interaction of Jagged2 with 
supports both - and -lineage differentiation. In addition, 
Jagged2 is the most potent Notch ligand to activate signaling 
through the Notch3 receptor, which in term is a stronger 
Figure 8. Jagged2-mediated inhibition of 
TCR- chain expression represses -lineage 
differentiation. (A) Flow cytometric analysis  
of intracellular CD3 and TCR- expression in 
CD34+CD4CD1a thymic progenitors after  
3 wk of coculture on OP9 stromal cells express-
ing the different Notch ligands. Data are repre-
sentative of three independent experiments.  
(B) The mean frequency of icTCR-+ cells gener-
ated from CD34+CD4CD1a thymic progenitors 
on the various OP9 stromal cells. Data are de-
rived from three independent experiments (error 
bars indicate SEM, * = P < 0.05). (C–E) Flow cyto-
metric analysis of human CD34+CD4–CD1a– thy-
mic progenitors transduced with control, TCR-, 
or TCR- after coculture on OP9 stromal cells 
expressing the different human Notch ligands, as 
indicated above the dot plots. Numbers in top 
right quadrants indicate the percentage of TCR-
+CD3+ cells (C), CD4+CD8+ DP cells (D), or 
TCR-+CD3+ cells (E). (F–H) Bar diagrams show 
the absolute numbers of TCR-+CD3+ cells  
(F), CD4+CD8+ DP cells (G), or TCR-+CD3+ 
cells (H) obtained after OP9 coculture with the 
different Notch ligands. Error bars represent 
means and SEM of three independent experi-
ments (D4 = DLL4, J1 = JAG1, and J2 = JAG2).
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because these Notch target genes need to be further up-
regulated upon T-lineage commitment to reach their peak at 
the DN3 stage (Taghon et al., 2006). The inability of Jagged1 
to induce DTX1, NRARP, and NOTCH3 was also evident 
in human CB-derived HSCs and might explain why Jagged1 
was not sufficient to induce T-lineage specification in human 
HPCs (Van de Walle et al., 2011). Further studies will need to 
clarify which Notch target genes are essential for initiating 
the T-lineage differentiation program.
Importantly, the early up-regulation of Notch3 during 
human T cell development in comparison with the mouse 
might explain the difference in Notch dependency of TCR- 
and TCR- T cell differentiation that is observed between 
both species (Washburn et al., 1997; Ciofani et al., 2006; 
Garbe et al., 2006; Taghon et al., 2006; Van de Walle et al., 
2009). In humans, both types of T cells start to diverge at the 
CD34+CD1+ stage when Notch3 is already highly expressed 
(Van de Walle et al., 2009), allowing Notch3 to influence this 
lineage choice through activation of Jagged2 that is abun-
dantly expressed by human TECs (Van de Walle et al., 2011). 
In contrast, Notch3 expression in the mouse peaks at the 
DN3 stage (Taghon et al., 2006; Shi et al., 2011), after the onset 
of  versus  T lineage bifurcation (Ciofani et al., 2006). 
Although there is clear detectable Notch3 expression at the 
DN2 stage when  and  T cells start to diverge (Shi et al., 
2011), it is unclear if these levels are sufficient to mediate these 
developmental processes, especially because recent data revealed 
no obvious defect in mouse  T cell development in the 
absence of Notch3 (Shi et al., 2011; Suliman et al., 2011). In 
addition, it is unclear how much Jagged2 protein is expressed 
by the TECs of the mouse, and in situ RNA expression analy-
sis suggests that DLL4 is more abundantly expressed in the 
mouse cortex compared with Jagged2 (Heinzel et al., 2007), 
raising the possibility that Notch3 might not be sufficiently acti-
vated to mediate this early developmental T cell choice. Nev-
ertheless, the observation that Jagged2-deficient mice display a 
reduction in fetal  T cell development is consistent with 
our human findings (Jiang et al., 1998).
The block in TCR- T cell differentiation was not com-
plete upon Notch3 inhibition or in the absence of Jagged2, 
which is consistent with the observation that Notch1 activa-
tion can also induce  T cell development. However, from the 
FTOC experiments it is obvious that at least part of human 
 T cells require Jagged2-mediated Notch3 activation for 
their development. Given our observation that the generation 
of a TCR- chain is impaired in Jagged2 cocultured thymo-
cytes and because introduction of a functional TCR- chain 
fully restores  T cell development under these conditions, 
it is clear that the failure of TCR- chain production is caus-
ing the inhibition of TCR- differentiation that is induced 
upon Jagged2/Notch3 signaling, thereby favoring the develop-
ment of  T cells. Given that Notch3 continues to be expressed 
in DP thymocytes that are the immediate precursors of   
T cells, we speculate that Notch3 might also be important for 
allelic exclusion and prevention of further TCR- chain 
rearrangements when the rearrangement machinery is again 
Notch3 explains why the Notch signal strength hierarchy for 
the different human Notch ligands is different for thymocytes 
compared with for HPCs that only express Notch1 and 
Notch2 (Van de Walle et al., 2009), conditions in which DLL4 
induces the strongest Notch ligand (Van de Walle et al., 2011). 
This indicates that the induction of Notch signal strength in 
signal-receiving cells is highly dependent on its own reper-
toire of Notch receptors and on the combination of ligands 
expressed by the signal-sending cell. Because thymocytes mi-
grate through the cortex during their development, our re-
sults propose that competition between Notch ligands for 
engagement of Notch1 and Notch3 will determine the T cell 
lineage outcome. Despite the abundance of Jagged2 in the 
human cortex, we anticipate that the strong interaction be-
tween DLL4 and Notch1, which results in a strong Notch1 
activation, prevents a predominant induction of human   
T cell development.
Recently, we have shown that Jagged1 does not induce a 
sufficient strong Notch signal in extrathymic human and mouse 
HPCs to induce T cell development in contrast to Jagged2, 
DLL1, and DLL4 (Van de Walle et al., 2011). Here, we demon-
strate that the weak Notch signal that is induced by Jagged1 
is capable of generating DP and TCR-+CD3+ thymo-
cytes from uncommitted postnatal thymocytes from human—
in agreement with previous observations (Dontje et al., 2006; 
Van de Walle et al., 2009)—but not from mouse. Consis-
tently, we show that Jagged1 does not support  T cell de-
velopment in human, whereas this ligand is sufficient for 
murine TCR- T cell differentiation, illustrating the oppos-
ing Notch signaling requirements between mouse and human 
(Taghon and Rothenberg, 2008; Taghon et al., 2012). This 
difference corresponds with a differential Notch activation sta-
tus during intrathymic T cell development between mouse and 
human as illustrated by the expression levels of Notch target 
genes in both species. In humans, it is clear that the strongest 
Notch signals are delivered in uncommitted CD34+CD1 
thymocytes as they express the highest levels of DTX1 and 
NRARP, genes which are highly sensitive to changes in 
Notch activation (Van de Walle et al., 2009). In contrast, Notch 
target genes peak at the DN3 stage of mouse T cell develop-
ment when T cell commitment is completed (Taghon et al., 
2006; Tydell et al., 2007;  Yashiro-Ohtani et al., 2009), a clear 
difference compared with human (Van de Walle et al., 2009). 
Also NOTCH3, whose expression is induced upon Notch1 
signaling, is expressed earlier during human compared with 
during mouse T cell development. Because our results show 
that Jagged1 is incapable of activating these target genes 
(DTX1, NRARP, and NOTCH3), human postnatal thymo-
cytes can further differentiate along the -lineage, as up-
regulation of these genes is apparently no longer needed for 
further differentiation along that pathway. Because human 
thymocytes continue to express NOTCH3 after the induc-
tion of T-lineage commitment, it is unlikely that Jagged1 is 
involved in vivo in these early stages of human -lineage 
differentiation. Mouse thymocytes, however, fail to generate 
DP -lineage cells in OP9-JAG1 cocultures, presumably 
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construct encoding full length Notch1 was provided by W. Pear (University 
of Pennsylvania, Philadelphia, PA). Viruses encoding functional TCR trans-
genes were LZRS-IRES-TCR-EGFP (TCR; Taghon et al., 2009) and 
LZRS-IRES-TCR-EGFP (TCR, provided by D. Vermijlen, ULB, Gos-
selies, Belgium; Vermijlen et al., 2010). Retroviral transduction of thymo-
cytes has been described (Taghon et al., 2009).
OP9 cocultures. Purified progenitors were seeded onto plates (24-well or 
96-well) confluent with OP9-DLL4, OP9-JAG1, or OP9-JAG2 cells and 
these cells have been previously well described to express similar levels of 
each Notch ligand (Van de Walle et al., 2011; Klinakis et al., 2011). OP9 
cocultures were all performed in -MEM media (Invitrogen) supple-
mented with 20% heat-inactivated FCS (Hyclone) plus 100 U/ml penicil-
lin, 100 µg/ml streptomycin, and 2 mM l-glutamine (all from Invitrogen). 
CD34+CD4CD1 or CD34+CD4CD1+ cells were cultured in the pres-
ence of 5 ng/ml IL-7, 5 ng/ml Flt-3L, and 5 ng/ml SCF. For OP9 cocultures 
started with retrovirally transduced CD34+CD4CD1 or CD34+CD4CD1+ 
progenitors, EGFP+ transduced cells were first sorted and subsequently 
subjected to coculture. For -secretase inhibition (GSI) experiments, dif-
ferent concentrations of DAPT (0 µM–0.2 µM–0.5 µM–1 µM) were added 
to the cocultures and an equal concentration of DMSO (0 µM GSI) was 
added as control. Notch3 blocking experiments were performed by add-
ing 1 or 5 µg/ml of the G3 isotype control or A4 anti-Notch3 antibody 
(provided by C. Siebel, Genentech, San Francisco, CA; Li et al., 2008). 
Every 2–3 d, half of the medium was refreshed to maintain antibody con-
centrations. Cocultures were harvested by forceful pipetting at the indicated 
time points.
FTOC. FTOCs with control, ICN1, or ICN3 transduced cells were per-
formed as described previously (Taghon et al., 2001). NOD-LtSz-scid/scid 
(NOD-SCID) mice (originally purchased from The Jackson Laboratory) were 
obtained from our own specific pathogen-free breeding facility. To perform 
FTOCs with JAG1- and JAG2-deficient fetal thymic lobes, homozygous 
Jag1lox/lox mice (Mancini et al., 2005) or Jag2lox/lox mice (Xu et al., 2010) were 
crossed to Foxn1-Cre mice (gift from N. Manley, University of Georgia, Athens, 
GA; Gordon et al., 2007) to generate Jag1lox/wtFoxn1-Cre+/ and Jag2lox/wt-
Foxn1-Cre+/ mice, respectively. These animals were subsequently inter-
crossed to obtain Jag1lox/loxFoxn1-Cre+/ and Jag1lox/loxFoxn1-Cre/ mice, 
and Jag2lox/loxFoxn1-Cre+/ and Jag2lox/loxFoxn1-Cre/ mice. Fetuses from these 
intercrossings were isolated at fetal day 15–15.5 of gestation and fetal thymic 
lobes were treated for 5 d with 1.35 mM 2-deoxyguanosine to remove all 
endogenous mouse thymocytes. Subsequently, between 5,000 and 10,000 
human progenitor cells were added to each lobe in 2-d hanging drop cul-
tures, before further culture as described above for FTOCs. Fetal liver from 
the same fetus was used to genotype the animals. All mice were treated ac-
cording to the guidelines of the Laboratory Animal Ethical commission of 
the University Hospital of Ghent.
Monoclonal antibodies and flow cytometry. Cell suspensions obtained 
from cocultures were first blocked with anti–mouse FcRII/III (clone 2.4.G2) 
and human IgG (Fcblock; Miltenyi Biotec) to avoid nonspecific binding. 
Cell suspensions obtained after FTOCs were also blocked with anti–mouse 
FcRII/III mAb and stained with rat anti–mouse monoclonal antibody CD45-
cychrome to gate out mouse cells during flow cytometry. Subsequently, cells 
were stained with combinations of anti–human monoclonal antibodies as in-
dicated and as described previously (Taghon et al., 2009; Van de Walle et al., 
2009). OP9 cocultures were always gated on human CD45+ cells. Cells were 
examined for the expression of cell surface markers on an LSRII (BD) and 
human viable cells were gated by excluding propidium iodide–positive cells 
from analysis.
Reverse transcription PCR. For gene expression analysis, CD34+ thymo-
cytes were cultured for 24 h in tissue culture plates that were precoated with 
Fc-tagged Notch ligands as previously described (Van de Walle et al., 2011). 
In the case of ICN1, ICN3, and MSCV transduced cells, cells were harvested 
activated to induce TCR- rearrangements. Interestingly, the 
generation of a functional TCR- chain has been shown to 
be dependent on Notch1 signaling in the mouse (Wolfer et al., 
2002) and presumably also in humans (De Smedt et al., 2005). 
Although our gene expression analysis only reveals quantitative 
and no qualitative differences between Notch1 and Notch3 in 
their potential to activate or repress Notch target genes, previ-
ous work has proposed that Notch3 can inhibit Notch1 function 
(Beatus et al., 1999), leaving the possibility that TCR- chain 
rearrangements are differentially affected by Notch1 and Notch3. 
Although currently impossible because of the lack of specific 
ICN3 reagents, genome-wide ChIP studies will help to clarify 
whether Notch1 and Notch3 target the same genes or not.
Overall, our results reveal a critical role for Notch receptor–
ligand interactions in the development of T cells bearing either 
a  or  TCR and, as such, propose a novel role for Notch 
signaling in the generation of these TCRs, possibly by affect-
ing TCR rearrangements. Although the expression of such a  
or  TCR does not necessarily correspond with their fur-
ther differentiation along the DN - or DP -lineages, 
respectively, we did observe a correlation between TCR- 
T cell development and the generation of CD4+CD8+ DP 
thymocytes in our cultures. Such a correlation between the 
TCR and the corresponding lineage differentiation program 
is also observed in the majority of - and -lineage T cells 
in wild-type mice, but it was also clearly demonstrated that 
the strength of signal through the TCR is critical in establish-
ing the - versus -lineage choice (Haks et al., 2005; Hayes 
et al., 2005), with Notch signal strength presumably playing 
a modulatory role (Garbe and von Boehmer, 2007). Such ele-
gant genetic studies are difficult to achieve in humans but now 
become feasible using gene-modified human ES cells that can 
differentiate along the T cell pathway in vitro (Timmermans 
et al., 2009). These studies will be required to define the precise 
contributions of TCR and Notch signal strengths in mediat-
ing the - versus -lineage choice in human. Neverthe-
less, based on the current evidence from in vitro studies using 
mouse and human ex vivo–isolated progenitors, it is clear 
that the requirements for Notch signaling during the early 
stages of T cell development are distinct between both spe-
cies (Taghon et al., 2012). The results in this manuscript in-
dicate that this may occur at the level of TCR generation.
MATERIALS AND METHODS
Isolation of thymocytes and retroviral transduction. Pediatric thymus 
samples were obtained and used according to the guidelines of the Medical 
Ethical Commission of Ghent University Hospital (Belgium). CD34+ thy-
mocytes were enriched using CD34 magnetic-activated cell-sorting (MACS; 
Miltenyi Biotec), according to the manufacturer’s instructions. Enriched 
CD34+ thymocytes were labeled with CD34-APC, CD4-PE, and CD1-FITC 
to sort (FACSAria II; BD) CD34+CD4CD1a and CD34+CD4CD1a+ 
fractions. Isolation of other thymocyte subsets has been described previously 
(Taghon et al., 2009; Van de Walle et al., 2009). Purity of the sorted cells 
was checked on a FACSCalibur (BD) and was always >98%. cDNA encod-
ing constitutively active or full-length Notch3 was subcloned from previ-
ously described constructs (Wang et al., 2007) into the multicloning site of 
the retroviral vector MSCV-EGFP. Generation of the plasmid containing 
ICN1 has been described previously (De Smedt et al., 2002) and the MSCV 
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and EGFP+ cells were sorted. Cells were resuspended in RLT buffer and 
stored at 70°C before RNA isolation. RNA was extracted using RNeasy 
RNA isolation kit (QIAGEN) and converted into cDNA using Superscript 
RT II (Invitrogen).
Real-time PCR reactions were performed using the qPCR Core kit for 
SYBR Green I (Eurogentec) on a 7300 Real-time PCR system (Applied 
Biosystems). Relative expression levels were calculated for each gene using 
the Ct method using GAPDH or -actin for normalization.
Luciferase reporter assay and binding studies. Luciferase reporter 
assays were performed as previously described (Van de Walle et al., 2011). 
In brief, U2OS Tet-on flp-in cells bearing isogenic transgenes encoding 
Notch1-Gal4 or Notch3-Gal4 chimeric receptors (gift from J. Aster, Harvard 
University, Boston, MA; Li et al., 2008) were transfected with Gal4-firefly 
luciferase and pRL-TK Renilla reporter plasmid. After 1 d, K562 cells 
expressing Notch ligands were added together with 2 µg/ml tetracycline. 
1 d later, luciferase activity was measured in cell lysates using a dual luciferase 
reporter system (Promega).
Binding studies were performed using K562 cells retrovirally transduced 
with the different Notch ligands (Delta-like 4, Jagged1, and Jagged2) or the 
empty vector LZRS-EGFP as a control (Van de Walle et al., 2011). The K562 
cells were washed in complete IMDM and aliquoted at 2 × 105 cells in 100 µl 
of binding buffer (HBSS containing 1 mM CaCl2, 1% BSA, and 0.05% NaN3). 
The cells were incubated with the Fc-tagged Notch receptors (R&D Systems) 
or human IgG1 isotype control (Enzo Life Sciences) at 4°C for 40 min. After 
washing two times with binding buffer, the cells were incubated with a 
PE-conjugated anti–human Fc (eBioscience).
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